Detalhe da pesquisa
1.
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
N Engl J Med
; 385(24): 2230-2240, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34879449
2.
Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500â cells·µL-1.
Eur Respir J
; 59(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487538
3.
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
J Allergy Clin Immunol Pract
; 10(10): 2695-2709, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35636689
4.
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies.
J Allergy Clin Immunol Pract
; 10(3): 732-741, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954123
5.
Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines.
J Allergy Clin Immunol Glob
; 1(1): 9-15, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37780074
6.
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study.
Lancet Respir Med
; 10(1): 11-25, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597534
7.
Plasma cortisol levels in acute asthma.
Indian J Pediatr
; 70(12): 965-8, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14719785